Tesla (TSLA) is set to release its financial results for the fourth quarter of 2024 after the markets close on Wednesday, Jan ...

Stifel analysts maintained a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) with a steady price target of $21.00. According to InvestingPro data, the stock currently trades at $6.40, with analyst ...

Oracle, driven by AI and cloud, projects a 15% stock price CAGR potential over five years, and a fair valuation amid a ...

Explore the stock market outlook for the first six months of 2025. Learn key trends, forecasts and insights to help guide ...

Nvidia Corporation to “Buy” despite the stock's 11% pre-market drop, viewing the dip as a buying opportunity amid market ...

Join us on the SBI Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay in ...

In international markets, chipmaking and electrification companies saw pressure on the fears over the DeepSeek AI service.

The market is expected to consolidate with a negative bias, while volatility is expected to remain high. Below are some ...

TD stock had a rough 2024, but in 2025 what should investors be watching now? Join More Than 30,000 Premium Members Receiving ...

Budget 2025, Q3 results, foreign fund outflow, US Fed verdict, among others, will dictate trends this week. D-Street experts ...

Meta Platforms and Salesforce have seen their share prices increase 350% and 115%, respectively, in the last two years. Meta ...